657-24-9 98%

Corporate Profile
Towards Better Healthcare…
Wanbury Limited, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation. Wanbury’s major trust area lies in Active Pharmaceutical Ingredient (API) Sales & Marketing in over 50 countries and Pan-India Formulation presence.

Active Pharmaceutical Ingredient :
Wanbury has a basket of over 13 API products.
It is the largest manufacturer of Metformin with over 8500 tons per year.
It has the larger customer base in Europe & US for Tramadol & Setraline (API)
Wanbury exports to over 50 countries, 65% of which comprises of regulated markets.
Has two US-FDA approved multi-product API facilities and one plant under operation for semi-regulated
markets.
Has been the preferred supplier to some of the top five generic players of the world.
Formulations :
Pan-India presence in ethical formulations with a portfolio of close to 70 brands.
Strong presence in gynecology, orthopedics, heamatinics, anti-diabetic, neutraceuticals, gastro intestinal,
stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics and general practitioner.